Clear Value Plus brings additional information into iKnowMed

How EHR data can improve
quality
Debra Patt, MD MBA MPH
Director of Policy, Texas Oncology
Director of Outcomes Research McKesson Specialty Health
ASCO Slides Courtesy of Dr. Robert Miller, Director of Quality, ASCO
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
The New Frontier
2
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Objectives
 Discuss technology enabling volume to value transition
 Quality Reporting, PQRS, APM, MIPS
 Discuss the role of Clinical Decision Support Tools -Pathways
• To enhance data acquisition
• To nudge evidence based decision making
 Discuss the use of predictive analytics to improve care
3
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
The Triple Aim
4
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
5
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
6
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
7
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Cancerlinq
8
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Cancerlinq
9
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
10
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
11
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
12
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Value Pathways powered by NCCN:
Leadership in evidence-based medicine
• Evidence-based protocols to reduce
treatment variability, hospitalizations, and
excessive care at the end of life
• Refinement of the NCCN Guidelines®
• Direct collaboration with NCCN physicians
• Selected based on efficacy, toxicity and cost
• Accessible for physicians through Clear
Value Plus℠ technology
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Clear Value Plus brings additional information
into iKnowMed
Clear Value Plus
• Extension of iKnowMed EHR
• Flexible access to leading content:
• Value Pathways powered by NCCN
• NCCN Guidelines
• Clinical trials regimens
• Fast to use, simple to learn
• Real-time reporting on compliance,
performance and outcomes
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Clear Value Plus integration: iKnowMed EHR
Clinical facts transferred to CVP,
additional data entered
All relevant details and
Pathways
and to
NCCN Guidelines
Normal click to ‘Order
summary
returned
regimen’ from within iKM
charttreatment options highlighted
Progress Note
Selected regimen goes through
normal order entry process
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Pathways and Guidelines reporting
 Suite of off-the-shelf reports supported through CVP web portal –
currently focused on Guidelines/Pathways adherence
 Data and report features:
• Real-time
• Based on entered treatment decisions for each provider/patient
• Can be filtered by:
– Provider
– Site
– Plan type
– Disease
– Time period
• All data can be filtered and exported to flat files
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Reporting – Compliance trend (NCCN
Guidelines) – filtered by provider
NOTE: Demo data – does not imply actual compliance results
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Reporting – Exception reasons
NOTE: Demo data – does not imply actual compliance results
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Level Setting
19
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
US
Oncology
Pilot with
PCCI
Oncology
Hospitalizations
Proprietary
and
Confidential
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty
Health. All
rights
reserved.
© 2015 PCCI
PCCI
Started as the innovation arm of
Who we are.
Parkland, the only safety net hospital
Our
Mission
To help save a life.
in the Dallas. TX area. Emerging out
of a safety net hospital meant we
Our
Vision
had to look at factors outside the
pccipieces.org
hospital to improve our underserved
To deploy predictive and
population’s health.
surveillance solutions around the
oprietary and
Confidential
© 2015
PCCIby McKesson Specialty Health. © 2015 McKesson Specialty
Proprietary
and
Confidential
© 2015 PCCI
The US
Oncology Network
is supported
Health. All
rights
reserved.
world that make Healthcare safer,
simpler and less stressful.
Pieces™
Platform
User Interface
Community Health User
Interface
Algorithms
Plexus
Pieces™
Iris
WhiteCoat
Services
A total framework for
adverse events
Proprietary
and
Confidential
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty
Health. All
rights
reserved.
© 2015 PCCI
Proprietary
and
Confidential
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty
Health. All
rights
reserved.
© 2015 PCCI
Modeling
-Advanced Pancreatic and Lung Cancers
-Substantial structured data on patient, tumor, and treatment characteristics
-Comprehensive inpatient and outpatient data
-Evaluating Absolute/Relative Risk ER visit &Hospitalization in 1, 3, & 6 months
-Drivers of risk for a given patient
- Further stratification by treatment options
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Proprietary
and
Confidential
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty
Health. All
rights
reserved.
© 2015 PCCI
26
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
Proprietary
and
Confidential
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty
Health. All
rights
reserved.
© 2015 PCCI
28
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.
29
Thank you
[email protected]
The US Oncology Network is supported by McKesson Specialty Health. © 2015 McKesson Specialty Health. All rights reserved.